Cargando…
On the relationship between androgen-deprivation therapy for prostate cancer and risk of infection by SARS-CoV-2
Autores principales: | , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
European Society for Medical Oncology. Published by Elsevier Ltd.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7299865/ https://www.ncbi.nlm.nih.gov/pubmed/32562741 http://dx.doi.org/10.1016/j.annonc.2020.06.005 |
_version_ | 1783547457388412928 |
---|---|
author | Caffo, O. Zagonel, V. Baldessari, C. Berruti, A. Bortolus, R. Buti, S. Ceresoli, G.L. Donini, M. Ermacora, P. Fornarini, G. Fratino, L. Masini, C. Massari, F. Mosca, A. Mucciarini, C. Procopio, G. Tucci, M. Verri, E. Zucali, P. Buttigliero, C. |
author_facet | Caffo, O. Zagonel, V. Baldessari, C. Berruti, A. Bortolus, R. Buti, S. Ceresoli, G.L. Donini, M. Ermacora, P. Fornarini, G. Fratino, L. Masini, C. Massari, F. Mosca, A. Mucciarini, C. Procopio, G. Tucci, M. Verri, E. Zucali, P. Buttigliero, C. |
author_sort | Caffo, O. |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-7299865 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | European Society for Medical Oncology. Published by Elsevier Ltd. |
record_format | MEDLINE/PubMed |
spelling | pubmed-72998652020-06-18 On the relationship between androgen-deprivation therapy for prostate cancer and risk of infection by SARS-CoV-2 Caffo, O. Zagonel, V. Baldessari, C. Berruti, A. Bortolus, R. Buti, S. Ceresoli, G.L. Donini, M. Ermacora, P. Fornarini, G. Fratino, L. Masini, C. Massari, F. Mosca, A. Mucciarini, C. Procopio, G. Tucci, M. Verri, E. Zucali, P. Buttigliero, C. Ann Oncol Letter to the Editor European Society for Medical Oncology. Published by Elsevier Ltd. 2020-10 2020-06-18 /pmc/articles/PMC7299865/ /pubmed/32562741 http://dx.doi.org/10.1016/j.annonc.2020.06.005 Text en © 2020 European Society for Medical Oncology. Published by Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Letter to the Editor Caffo, O. Zagonel, V. Baldessari, C. Berruti, A. Bortolus, R. Buti, S. Ceresoli, G.L. Donini, M. Ermacora, P. Fornarini, G. Fratino, L. Masini, C. Massari, F. Mosca, A. Mucciarini, C. Procopio, G. Tucci, M. Verri, E. Zucali, P. Buttigliero, C. On the relationship between androgen-deprivation therapy for prostate cancer and risk of infection by SARS-CoV-2 |
title | On the relationship between androgen-deprivation therapy for prostate cancer and risk of infection by SARS-CoV-2 |
title_full | On the relationship between androgen-deprivation therapy for prostate cancer and risk of infection by SARS-CoV-2 |
title_fullStr | On the relationship between androgen-deprivation therapy for prostate cancer and risk of infection by SARS-CoV-2 |
title_full_unstemmed | On the relationship between androgen-deprivation therapy for prostate cancer and risk of infection by SARS-CoV-2 |
title_short | On the relationship between androgen-deprivation therapy for prostate cancer and risk of infection by SARS-CoV-2 |
title_sort | on the relationship between androgen-deprivation therapy for prostate cancer and risk of infection by sars-cov-2 |
topic | Letter to the Editor |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7299865/ https://www.ncbi.nlm.nih.gov/pubmed/32562741 http://dx.doi.org/10.1016/j.annonc.2020.06.005 |
work_keys_str_mv | AT caffoo ontherelationshipbetweenandrogendeprivationtherapyforprostatecancerandriskofinfectionbysarscov2 AT zagonelv ontherelationshipbetweenandrogendeprivationtherapyforprostatecancerandriskofinfectionbysarscov2 AT baldessaric ontherelationshipbetweenandrogendeprivationtherapyforprostatecancerandriskofinfectionbysarscov2 AT berrutia ontherelationshipbetweenandrogendeprivationtherapyforprostatecancerandriskofinfectionbysarscov2 AT bortolusr ontherelationshipbetweenandrogendeprivationtherapyforprostatecancerandriskofinfectionbysarscov2 AT butis ontherelationshipbetweenandrogendeprivationtherapyforprostatecancerandriskofinfectionbysarscov2 AT ceresoligl ontherelationshipbetweenandrogendeprivationtherapyforprostatecancerandriskofinfectionbysarscov2 AT doninim ontherelationshipbetweenandrogendeprivationtherapyforprostatecancerandriskofinfectionbysarscov2 AT ermacorap ontherelationshipbetweenandrogendeprivationtherapyforprostatecancerandriskofinfectionbysarscov2 AT fornarinig ontherelationshipbetweenandrogendeprivationtherapyforprostatecancerandriskofinfectionbysarscov2 AT fratinol ontherelationshipbetweenandrogendeprivationtherapyforprostatecancerandriskofinfectionbysarscov2 AT masinic ontherelationshipbetweenandrogendeprivationtherapyforprostatecancerandriskofinfectionbysarscov2 AT massarif ontherelationshipbetweenandrogendeprivationtherapyforprostatecancerandriskofinfectionbysarscov2 AT moscaa ontherelationshipbetweenandrogendeprivationtherapyforprostatecancerandriskofinfectionbysarscov2 AT mucciarinic ontherelationshipbetweenandrogendeprivationtherapyforprostatecancerandriskofinfectionbysarscov2 AT procopiog ontherelationshipbetweenandrogendeprivationtherapyforprostatecancerandriskofinfectionbysarscov2 AT tuccim ontherelationshipbetweenandrogendeprivationtherapyforprostatecancerandriskofinfectionbysarscov2 AT verrie ontherelationshipbetweenandrogendeprivationtherapyforprostatecancerandriskofinfectionbysarscov2 AT zucalip ontherelationshipbetweenandrogendeprivationtherapyforprostatecancerandriskofinfectionbysarscov2 AT buttiglieroc ontherelationshipbetweenandrogendeprivationtherapyforprostatecancerandriskofinfectionbysarscov2 |